Clinical Trials Sponsored by Infectious Diseases Institute, Uganda

Total 3503 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants

HIV Infections | Pregnancy

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Effects of Storage on Lactate in Blood Samples

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Treatment of Hepatitis C in Hemophilic Patients With HIV

HIV Infections | Hemophilia | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

China Case Control Avian Influenza

Influenza

China
National Institute of Allergy and Infectious Diseases...

Completed

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

HIV Infections
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Promoting Adherence to Anti-HIV Drug Regimens

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Strategies for Delivering Anti-HIV Therapy in South Africa

HIV Infections

South Africa
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Vitamin A Therapy for Tuberculosis

HIV Infections | Pulmonary Tuberculosis

Malawi
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

HIV Infections

United States
University of Notre Dame
Infectious Diseases Research Collaboration, Uganda; SC Johnson, A Family Company and other collaborators

Not yet recruiting

Spatial Repellents for Malaria Control (AEGIS Uganda)

Malaria

Uganda
University of California, San Francisco
Makerere University; Infectious Diseases Research Collaboration, Uganda; Makerere...

Completed

Early HIV Therapy in Patients With High CD4 Cell Counts (EARLI)

HIV

Uganda
National Institute of Allergy and Infectious Diseases...
ANRS, Emerging Infectious Diseases

Completed

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx (ILIADE)

HIV Infections

United States, France
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus (ELIMINATE)

Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety Study of SLV213 for the Treatment of COVID-19.

COVID-19

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT)

Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Advancing Transplantation Outcomes in Children (ADVANTage)

Kidney Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Kidney Transplant

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection

United States, Brazil, Peru
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety of Intravenous Apramycin in Adults

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

HIV Infections | Hepatitis B

Botswana, Thailand, United States, Zimbabwe, Haiti, Philippines, Brazil, Peru, South Africa, Uganda
National Institute of Allergy and Infectious Diseases...

Recruiting

Neonatal Phase 1 Valacyclovir Study

Herpes Simplex

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus (DIVERT)

Systemic Lupus Erythematosus

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Registry of Asthma Characterization and Recruitment 3 (RACR3) (RACR3)

Asthma

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)

Zika Virus

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

COVID-19

India
National Institute of Allergy and Infectious Diseases...

Completed

Anthrax AV7909 Liquid vs Lyophilized

Anthrax | Anthrax Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Flublok or Fluzone With Advax-CpG55.2 or AF03

Influenza | Influenza Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Ebola Disease | Immunisation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA (HVTN119)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

HIV Infections | Cytomegalovirus Infections | Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

Monkeypox

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Pretomanid in Adults With Hepatic Impairment

Tuberculosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Syphilis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males - A Sub-study of HPTN 083

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Suspended

Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

NNITS-Nitazoxanide for Norovirus in Transplant Patients Study

Gastroenteritis Norovirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers

Yellow Fever | Yellow Fever Immunisation

United States

Clinical Trials Sponsored by Infectious Diseases Institute, Uganda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations